Evaluation of Patients' and Parents' Quality of Life in a Randomized Placebo-Controlled Atomoxetine Study in Attention-Deficit/Hyperactivity Disorder-Reference-Cited by-同舟云学术

Evaluation of Patients' and Parents' Quality of Life in a Randomized Placebo-Controlled Atomoxetine Study in Attention-Deficit/Hyperactivity Disorder

Author:

Escobar Rodrigo¹,Montoya Alonso²,Polavieja Pepa²³,Cardo Esther⁴,Artigas Josep⁵,Hervas Amaia⁶,Fuentes Joaquín⁷

Affiliation:

1. EU Medical, Lilly Research Laboratories, Alcobendas, Spain.

2. Clinical Research, Lilly Research Laboratories, Alcobendas, Spain.

3. Pepa Polavieja is the responsible statistical expert for this study.

4. Laboratory of Neuropediatrics Neuroscience. University Institute of Research in Health (IUNICS). Son Llatzer Hospital, Mallorca, Spain.

5. Unitat de Neuropediatria. Hospital de Sabadell. Corporació Sanitària Parc Taulí, Barcelona, Catalonia, Spain.

6. Child and Adolescent Mental Health Unit. Department of Psychiatry. Hospital Mútua de Terrassa, Barcelona, Catalonia, Spain.

7. Child & Adolescent Psychiatry Unit. Policlínica Guipúzcoa, San Sebastián, Spain.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology, and Child Health

Link

Reference36 articles.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献